EconPapers    
Economics at your fingertips  
 

Mxra8 is a receptor for multiple arthritogenic alphaviruses

Rong Zhang, Arthur S. Kim, Julie M. Fox, Sharmila Nair, Katherine Basore, William B. Klimstra, Rebecca Rimkunas, Rachel H. Fong, Hueylie Lin, Subhajit Poddar, James E. Crowe, Benjamin J. Doranz, Daved H. Fremont and Michael S. Diamond ()
Additional contact information
Rong Zhang: Washington University School of Medicine
Arthur S. Kim: Washington University School of Medicine
Julie M. Fox: Washington University School of Medicine
Sharmila Nair: Washington University School of Medicine
Katherine Basore: Washington University School of Medicine
William B. Klimstra: University of Pittsburgh
Rebecca Rimkunas: Integral Molecular Inc.
Rachel H. Fong: Integral Molecular Inc.
Hueylie Lin: Washington University School of Medicine
Subhajit Poddar: Washington University School of Medicine
James E. Crowe: Vanderbilt University Medical Center
Benjamin J. Doranz: Integral Molecular Inc.
Daved H. Fremont: Washington University School of Medicine
Michael S. Diamond: Washington University School of Medicine

Nature, 2018, vol. 557, issue 7706, 570-574

Abstract: Abstract Arthritogenic alphaviruses comprise a group of enveloped RNA viruses that are transmitted to humans by mosquitoes and cause debilitating acute and chronic musculoskeletal disease 1 . The host factors required for alphavirus entry remain poorly characterized 2 . Here we use a genome-wide CRISPR–Cas9-based screen to identify the cell adhesion molecule Mxra8 as an entry mediator for multiple emerging arthritogenic alphaviruses, including chikungunya, Ross River, Mayaro and O’nyong nyong viruses. Gene editing of mouse Mxra8 or human MXRA8 resulted in reduced levels of viral infection of cells and, reciprocally, ectopic expression of these genes resulted in increased infection. Mxra8 bound directly to chikungunya virus particles and enhanced virus attachment and internalization into cells. Consistent with these findings, Mxra8–Fc fusion protein or anti-Mxra8 monoclonal antibodies blocked chikungunya virus infection in multiple cell types, including primary human synovial fibroblasts, osteoblasts, chondrocytes and skeletal muscle cells. Mutagenesis experiments suggest that Mxra8 binds to a surface-exposed region across the A and B domains of chikungunya virus E2 protein, which are a speculated site of attachment. Finally, administration of the Mxra8–Fc protein or anti-Mxra8 blocking antibodies to mice reduced chikungunya and O’nyong nyong virus infection as well as associated foot swelling. Pharmacological targeting of Mxra8 could form a strategy for mitigating infection and disease by multiple arthritogenic alphaviruses.

Date: 2018
References: Add references at CitEc
Citations: View citations in EconPapers (7)

Downloads: (external link)
https://www.nature.com/articles/s41586-018-0121-3 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:557:y:2018:i:7706:d:10.1038_s41586-018-0121-3

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/s41586-018-0121-3

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:nature:v:557:y:2018:i:7706:d:10.1038_s41586-018-0121-3